157 related articles for article (PubMed ID: 31607922)
1. Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan.
Lin YC; Tsai CS; Li IH; Tsai YT; Huang TY; Lee KF; Lin CS; Shih JH; Kao LT
Front Pharmacol; 2019; 10():1074. PubMed ID: 31607922
[TBL] [Abstract][Full Text] [Related]
2. Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-Based Study.
Chung SD; Ho JD; Lin HC; Kao LT; Tsai MC
J Glaucoma; 2015; 24(5):e116-20. PubMed ID: 25642815
[TBL] [Abstract][Full Text] [Related]
3. Healthcare Service Utilization by Patients with Obstructive Sleep Apnea: A Population-Based Study.
Kao LT; Lee HC; Lin HC; Tsai MC; Chung SD
PLoS One; 2015; 10(9):e0137459. PubMed ID: 26339792
[TBL] [Abstract][Full Text] [Related]
4. Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant.
Bunniran S; Lee E; Kamble P; Suehs B; Franks B; Schwartz J; Thal G; Spalding J
J Med Econ; 2018 Nov; 21(11):1067-1074. PubMed ID: 30032686
[TBL] [Abstract][Full Text] [Related]
5. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
Tsai SF; Cheng CY; Shu KH; Wu MJ
Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612
[TBL] [Abstract][Full Text] [Related]
6. Increased healthcare service utilizations for patients with dementia: a population-based study.
Chung SD; Liu SP; Sheu JJ; Lin CC; Lin HC; Chen CH
PLoS One; 2014; 9(8):e105789. PubMed ID: 25157405
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization and costs in patients with benign prostatic hyperplasia: a population-based study.
Chung SD; Tzeng YM; Lin HC; Huang CY
Asian J Androl; 2016; 18(6):942-945. PubMed ID: 26585701
[TBL] [Abstract][Full Text] [Related]
8. Healthcare Service Utilization for Practicing Physicians: A Population-Based Study.
Chiu YL; Kao S; Lin HC; Tsai MC; Lee CZ
PLoS One; 2016; 11(1):e0130690. PubMed ID: 26752592
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilisation for eating disorders among patients with depression: a cross-sectional study in Taiwan.
Yan CL; Kao LT; Yeh MK; Chien WC; Yeh CB
BMJ Open; 2019 Dec; 9(12):e032108. PubMed ID: 31888926
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine.
Neylan JF; Sullivan EM; Steinwald B; Goss TF
Am J Kidney Dis; 1998 Nov; 32(5):770-7. PubMed ID: 9820446
[TBL] [Abstract][Full Text] [Related]
11. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
Bardet V; Junior AP; Coste J; Lecoq-Lafon C; Chouzenoux S; Bernard D; Soubrane O; Lacombe C; Calmus Y; Conti F
Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250
[TBL] [Abstract][Full Text] [Related]
12. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
[TBL] [Abstract][Full Text] [Related]
13. A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada.
Prasad GV; Nash MM; Keough-Ryan T; Shapiro RJ
J Nephrol; 2010; 23(3):274-81. PubMed ID: 20383867
[TBL] [Abstract][Full Text] [Related]
14. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
[TBL] [Abstract][Full Text] [Related]
15. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
16. Trends in the use of maintenance immunosuppressive drugs among liver transplant recipients in Taiwan: a nationwide population-based study.
Huang YY; Hsu CC; Chou CL; Loong CC; Wu MS; Chou YC
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):661-7. PubMed ID: 26799240
[TBL] [Abstract][Full Text] [Related]
17. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients.
Israni A; Brozena S; Pankewycz O; Grossman R; Bloom R
Am J Kidney Dis; 2002 Mar; 39(3):E16. PubMed ID: 11877596
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
19. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
20. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
